학술논문
What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?
Document Type
Article
Source
Neuro-Oncology; Nov2023, Vol. 25 Issue 11, p1915-1917, 3p
Subject
Language
ISSN
15228517